Virtually via Zoom
Please join us virtually via Zoom on Tuesday, February 18, 2025, at 4:00 PM ET for the HIVPeCoT-TP T32 Career Series event. This session will feature Dr. Hannah Gordon, a classically trained molecular biologist with significant expertise in AI-guided, target-agnostic drug discovery platforms. Currently serving as the Chief Product Officer at Enveda Biosciences, she has been instrumental in leading teams of scientists to develop innovative and impactful drug programs. Dr. Gordon's academic background includes a PhD in Human Genetics and an MS in Clinical Investigation from the University of Utah, where she honed her skills in bridging the gap between basic research and clinical applications. Dr. Gordon will be presenting “Entrepreneurship in Biomedicine.”